Generation Bio (GBIO)
(Delayed Data from NSDQ)
$2.78 USD
-0.08 (-2.80%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $2.81 +0.03 (1.08%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for Generation Bio Co falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -126.61 | -136.64 | -119.15 | -80.52 | -61.32 |
Depreciation/Amortization & Depletion | 5.26 | 5.13 | 4.53 | 3.43 | 1.86 |
Net Change from Assets/Liabilities | 53.54 | 1.05 | 4.18 | -1.71 | 15.23 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.07 | 28.02 | 18.62 | 8.66 | 3.88 |
Net Cash From Operating Activities | -52.75 | -102.45 | -91.82 | -70.14 | -40.35 |
Property & Equipment | -7.40 | -8.80 | -5.85 | -5.52 | -19.91 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -2.30 | -183.71 | 198.90 | -199.68 | 67.89 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -9.70 | -192.52 | 193.05 | -205.20 | 47.99 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 36.55 | 13.62 | 215.63 | 326.32 | 0.10 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.73 | -0.63 | -0.96 | -3.23 | -0.02 |
Net Cash from Financing Activities | 35.82 | 12.99 | 214.67 | 323.10 | 0.08 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -26.63 | -281.97 | 315.90 | 47.76 | 7.72 |
Cash at Beginning of Period | 98.86 | 380.84 | 64.94 | 17.18 | 9.47 |
Cash at End of Period | 72.24 | 98.86 | 380.84 | 64.94 | 17.18 |
Diluted Net EPS | -1.96 | -2.35 | -2.12 | -2.95 | NA |
Fiscal Year End for Generation Bio Co falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -94.97 | -74.54 | -126.61 | -91.43 | -63.16 |
Depreciation/Amortization & Depletion | 2.58 | 1.31 | 5.26 | 3.94 | 2.65 |
Net Change from Assets/Liabilities | -22.64 | -17.06 | 53.54 | 48.10 | 49.53 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 61.80 | 58.60 | 15.07 | 11.62 | 8.11 |
Net Cash From Operating Activities | -53.23 | -31.70 | -52.75 | -27.77 | -2.87 |
Property & Equipment | -1.83 | -1.92 | -7.40 | -2.82 | -2.21 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 13.37 | 1.36 | -2.30 | -4.97 | 21.01 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 11.54 | -0.55 | -9.70 | -7.78 | 18.80 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.27 | 0.00 | 36.55 | 36.37 | 36.37 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.16 | -0.13 | -0.73 | -0.63 | -0.50 |
Net Cash from Financing Activities | 0.11 | -0.13 | 35.82 | 35.74 | 35.87 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -41.59 | -32.38 | -26.63 | 0.19 | 51.80 |
Cash at Beginning of Period | 72.24 | 72.24 | 98.86 | 98.86 | 98.86 |
Cash at End of Period | 30.65 | 39.86 | 72.24 | 99.05 | 150.66 |
Diluted Net EPS | -0.31 | -1.12 | -0.53 | -0.43 | -0.47 |